Aspect Biosystems
2013
FOUNDED
PRIVATE
STATUS
31-40
EMPLOYEES
Series A
LATEST DEAL TYPE
$20M
LATEST DEAL AMOUNT
14
INVESTORS
Description
Operator of a biotechnology company designed to innovate at the intersection of biology, medicine, and engineering to build living human tissues. The company's proprietary microfluidic 3D bioprinting technology is creating advances in understanding fundamental biology, disease research, development of novel therapeutics and regenerative medicine, enabling the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
- 1781 West 75th Avenue
- Vancouver, British Columbia V6P 6P2
- Canada
+1 (604) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Aspect Biosystems’s full profile, request a free trial.
Aspect Biosystems Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 09-Jan-2020 | $20M | 000.00 | Completed | Generating Revenue | |
| 7. Grant | 15-Nov-2018 | 00.00 | 00000 | Completed | Generating Revenue | |
| 6. Early Stage VC | 15-Mar-2018 | 00000 | 00000 | Completed | Generating Revenue | |
| 5. Early Stage VC | 31-Jul-2017 | Completed | Generating Revenue | |||
| 4. Seed Round | 01-Oct-2016 | Completed | Generating Revenue | |||
| 3. Seed Round | 30-Jun-2015 | Completed | Startup | |||
| 2. Grant | 01-Sep-2014 | $50.3K | Completed | Startup | ||
| 1. Accelerator/Incubator | 01-Nov-2013 | Completed | Startup |
Aspect Biosystems Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Organovo | Pending Transaction (M&A) | San Diego, CA | 00 | 0000 | 000000&0 | 0000 |
| 0000000 | Venture Capital-Backed | Villaz-Saint-Pierre, Switzerland | 0000 | |||
| 00000000 | Formerly VC-backed | Schlieren, Switzerland | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000 0000000000 | Venture Capital-Backed | Austin, TX | 0 | 00.000 | 0000000000 0 | 00.000 |
| 0000000000 | Venture Capital-Backed | Westminster, CO | 00 | 00000 | 000000000 00 | 00000 |
Aspect Biosystems Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Radical Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Rhino Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Western Economic Diversification Canada | Government | 000 0000 | 000000 0 | |||
| Genome British Columbia | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Civilization Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Aspect Biosystems Executive Team (6)
You’re viewing 5 of 6 executives. Get the full list »Aspect Biosystems Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Andrew Haughian | Pangaea Ventures | Board Member | 000 0000 | |
| Christopher Bissonnette Ph.D | Pallasite Ventures | Board Member | 000 0000 | |
| James Hatton | Aspect Biosystems | Board Member | 000 0000 | |
| Konrad Walus Ph.D | Aspect Biosystems | Co-Founder & Board Member | 000 0000 | |
| Tamer Mohamed | Aspect Biosystems | Co-Founder, Chief Executive Officer, President & Board Member | 000 0000 |